In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Business
·
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
French bond sell-off ‘reminiscent of the euro crisis’ as Paris proposes cuts and tax rises – business live
Rolling coverage of the latest economic and financial newsFrance’s government did try to cool the situation yesterday, b...
CitrixNews Staff
·
33 minutes ago
Business
Homes for sale in landmark towers in England and Scotland – in pictures
From a neo-baronial country house with turrets in acres of grounds in Scotland to a modernist tower block in a bustling ...
CitrixNews Staff
·
1 hour ago
Business
Lorry training firm 'riding out' record diesel price
Image caption, Steve Dulson, who founded Dulson Training in Shropshire in 2013, said it was costing hundreds of pounds m...
CitrixNews Staff
·
1 hour ago
Business
Would a gambling tax rise in the budget really shut shops and cost jobs?
Most of the betting industry is urging the chancellor not to double slot machine duty to raise up to £460m more a yearGa...
CitrixNews Staff
·
2 hours ago